3-hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelialcells - Involvement of geranylgeranylation of small G protein Rap1
K. Satoh et al., 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors block calcium-dependent tyrosine kinase Pyk2 activation by angiotensin II in vascular endothelialcells - Involvement of geranylgeranylation of small G protein Rap1, J BIOL CHEM, 276(19), 2001, pp. 15761-15767
We recently reported the calcium-dependent activation of tyrosine kinase Py
k2 by angiotensin II (Ang II) in pulmonary vein endothelial cells (PVEC). S
ince Pyk2 has no calcium binding domain, and neither Ca2+ nor Ca2+/calmodul
in directly activates Pyk2, it is not clear how Ca2+ transduces the signal
to activate Pyk2, a key tyrosine kinase, in the early events of Ang II sign
aling. In the present study, we investigated the mechanism of the calcium-d
ependent activation of Pyk2 in response to Ang II by using 3-hydroxy-3-meth
ylglutaryl-CoA reductase inhibitors and isoprenoid intermediates in PVEC, W
e have obtained substantial evidence indicating that Ang II activates Pyk2
through calcium-mediated activation of the geranylgeranylated small G prote
in Rap1 and the Rap1 association with Pyk2. Thus, the small G protein Rap1
is an intermediary signaling molecule linking Ang II-induced calcium signal
to Pyk2 activation in PVEC. In addition, our results indicate that 3-hydro
xy-3-methylglutaryl-CoA reductase inhibitors, a class of cholesterol-loweri
ng drugs, could interrupt Ang II signaling independent of cholesterol lower
ing in endothelial cells.